not yet recruiting (Feb): Integrated Molecular Profiling in Advanced Cancers Trial IMPACT) - Full Text View - ClinicalTrials.gov (breast, non-small cell lung, ovarian, colorectal)

Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT)

This study is not yet open for participant recruitment.

Verified February 2012 by University Health Network, Toronto

First Received on January 4, 2012. Last Updated on February 16, 2012 History of Changes


Primary Outcome Measures: Molecular profiling data to be made available in patient's electronic medical records. [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Genotyping assays including: 

 AKT1, HRAS, AKT2, JAK2, AKT3, KIT, BRAF, KRAS, CDK, MEK1, CTNNB1, MET, EGFR, NOTCH1, ERBB2, NRAS, FGFR1, PDGFRA, FGFR2, PIK3CA, FGFR3, RET, FGFR4, SMO, STK11